Trending news
Analyze
Pricing
Novo A/S

Novo A/S

Work at Novo A/S? Add yourself to this profile

Novo A/S

Elsewhere

Alexa global traffic share

02 Feb 2017
$30,000,000
Venture capital (Series D)

Tarveda Therapeutics Raises $30M in Series D Financing

FinSMEs
+1
05 Jan 2017
£23,000,000
Venture capital (Series B)

NeRRE Therapeutics picks up Series B funds

PE Hub
+2
15 Jun 2016
$33,000,000
Venture capital (Series B)

Rgenix Raises $33M, Preps Cancer Trial For Drug Shelved By GSK

Xconomy
+1
04 Apr 2016

Entasis Therapeutics Completes $50M Series B Financing

FinSMEs
+1
16 Mar 2016

Outpost Medicine raises $41 mln

PE Hub
+1
27 Jan 2016
$38,000,000
Venture capital (Series C)

Blend Rebrands as Tarveda, Raises $38M, and Spins Out Cancer Drug

Xconomy
+1
11 Jun 2015
17 Mar 2015
$27,343,269
Venture capital (Series E)
28 Apr 2014
$33,000,000
Venture capital
04 Jun 2013
$41,000,000
Venture capital (Series C)
Novartis Venture Fund, Venture Investors, Novo A/S, +6
19 Dec 2012

Stevenage BioScience Catalyst | The Stevenage Voice - February 2013 |

stevenagecatalyst
+1
12 Apr 2012
$20,000,000
Venture capital
14 Oct 2010
$20,000,000
Venture capital (Series F)
12 Oct 2010
12 Jul 2010
$78,000,000
Private equity
CPMG, Novo A/S
07 Dec 2009
$4,000,000
Venture capital
10 Apr 2009